Fig. 2From: Safety and efficacy of PG102P for the control of pruritus in patients undergoing hemodialysis (SNUG trial): study protocol for a randomized controlled trialTimeline of study procedures and outcome assessments. BDI Beck Depression Inventory, Ca calcium, ECG electrocardiogram, ECP eosinophilic cationic protein, IgE immunoglobulin E, iPTH intact parathyroid hormone, K potassium, KDQoL Kidney Disease Quality of Life, P phosphorus, VAS visual analog scaleBack to article page